Revamping of Pharmaceutical Manufacturing Processes

Year : 2024 | Volume :15 | Issue : 01 | Page : 38-44
By

Sravanthi Gandu

Naveen

Swetha.G

  1. Associate Professor Trinity College Of Pharmaceutical Sciences Telangana India
  2. Research Scholar Trinity College of Pharmaceutical Sciences Telangana India
  3. Regulatory affairs Executive Biocon Biologics, Bengaluru Karnataka India

Abstract

The pharmaceutical sector is entering a new era marked by technological advancements and an emphasis on sustainability and efficiency. A commitment to compliance can help boost consumer confidence and regulatory approval. This abstract explores the multifaceted approach to revamping pharmaceutical manufacturing processes, encompassing technological integration, regulatory compliance, and sustainability initiatives. Technological advancements, including automation, data analytics, and artificial intelligence, are playing a pivotal role in streamlining manufacturing operations. These innovations enhance precision, reduce time-to-market, and contribute to the overall agility of pharmaceutical production. The integration of cutting-edge technologies ensures not only increased production efficiency but also adherence to stringent regulatory standards, fostering a culture of continuous improvement and quality assurance. Regulatory compliance remains a cornerstone of revamped manufacturing processes. Strict adherence to Good Manufacturing Practices (GMP) and other regulatory guidelines ensures the safety, efficacy, and quality of pharmaceutical Products This dedication to adherence not only conforms to industry norms but also enhances consumer trust and regulatory endorsement. Initiatives are increasingly becoming integral to the revamping process, reflecting the industry’s commitment to environmental responsibility. Green chemistry practices, energy efficiency measures, waste reduction strategies, and responsible sourcing of raw materials collectively contribute to a more eco-friendly and socially responsible pharmaceutical manufacturing landscape. The continual overhaul of pharmaceutical manufacturing processes reflects a proactive response to the changing dynamics within the industry. This abstract provides a glimpse into the integration of advanced technologies, regulatory compliance, and sustainability initiatives, showcasing a holistic approach to modernizing pharmaceutical manufacturing for improved efficiency, quality, and societal impact.

Keywords: Pharmaceutical Manufacturing Processes, Robotics and automation, Good Manufacturing Practices, Revamping manufacturing process, Automating Data Analysis.

[This article belongs to Research & Reviews: A Journal of Pharmaceutical Science(rrjops)]

How to cite this article: Sravanthi Gandu, Naveen, Swetha.G. Revamping of Pharmaceutical Manufacturing Processes. Research & Reviews: A Journal of Pharmaceutical Science. 2024; 15(01):38-44.
How to cite this URL: Sravanthi Gandu, Naveen, Swetha.G. Revamping of Pharmaceutical Manufacturing Processes. Research & Reviews: A Journal of Pharmaceutical Science. 2024; 15(01):38-44. Available from: https://journals.stmjournals.com/rrjops/article=2024/view=136989




Browse Figures

References

1) N. Sarah Arden et all, Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future ,International Journal of Pharmaceutics 602 (2021) 120554 https://doi.org/10.1016/j.ijpharm.2021.120554 https://www.sciencedirect.com/science/article/pii/S03785173210035 9 8
2) Martin Gadsby, Elevating pharmaceutical manufacturing processes with real-time insights, European Pharmaceutical Review,2023. https://www.europeanpharmaceuticalreview.com/article/188595/elev ating-pharmaceutical-manufacturing-processes-with-real-time insights/
3) Hillary Dukart, Laurie Lanoue, Mariel Rezende and Paul Rutten October 10, 2022 Emerging from disruption: The future of pharma operations strategy https://www.mckinsey.com/capabilities/operations/our-insights/emerging-from-disruption-the-future-of-pharma-operations-strategy#/
4) Dariusz Jacoszek June 7,2021, Artificial Intelligence in Drug Discovery and Development, Nexocode, https://nexocode.com/blog/posts/artificial-intelligence-in-drug-discovery-and-development/
5) Kuehn S. Pharmaceutical manufacturing: Current trends and what’s next. Chemical Engineering Progress. 2018;114(12):23-9.
6) Jianjin Yu et all, Palladium-catalyzed conversion of phenols into tetrahydroacridines, Green Chemistry,2024,Doi: https://doi.org/10.1039/D3GC05210A
7) Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023 Jul 10;15(7):1916.
8) Singh S, Kumar R, Payra S, Singh SK. Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery. Cureus. 2023 Aug 30;15(8):e44359. doi: 10.7759/cureus.44359.
9) Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3
10) Sarkar C, Das B, Rawat VS, Wahlang JB, Nongpiur A, Tiewsoh I, Lyngdoh NM, Das D, Bidarolli M, Sony HT. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development. Int J Mol Sci. 2023 Jan 19;24(3):2026. doi: 10.3390/ijms24032026.
11) Bernie Brode, March 21,2022, AI and nanotechnology are working together to solve real-world problems, Stack overflow Blog , https://stackoverflow.blog/2022/03/21/ai-and-nanotechnology-are-working-together-to-solve-real-world-problems/
12) Gad, S. C. (Ed.). (2008). Pharmaceutical manufacturing handbook: production and processes (Vol. 5). John Wiley & Sons.


Regular Issue Subscription Review Article
Volume 15
Issue 01
Received February 2, 2024
Accepted March 18, 2024
Published March 30, 2024